OraSure Technologies Inc. (OSUR) Stock Price Up 5.4%
OraSure Technologies Inc. (NASDAQ:OSUR) rose 5.4% during mid-day trading on Wednesday . The stock traded as high as $6.29 and last traded at $6.29, with a volume of 628,946 shares. The stock had previously closed at $5.97.
OSUR has been the topic of several recent research reports. TheStreet cut shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 1st. Mizuho reissued an “outperform” rating and set a $8.00 price target on shares of OraSure Technologies in a research report on Tuesday. Zacks Investment Research cut shares of OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Wednesday, April 27th. BTIG Research reissued a “buy” rating and set a $9.00 price target on shares of OraSure Technologies in a research report on Wednesday, June 29th. Finally, Raymond James Financial Inc. cut shares of OraSure Technologies from an “outperform” rating to a “market perform” rating and set a $8.00 price target on the stock. in a research report on Monday, June 13th. Three research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. OraSure Technologies presently has an average rating of “Buy” and an average price target of $8.08.
The company has a market cap of $347.88 million and a P/E ratio of 35.22. The company’s 50-day moving average price is $7.09 and its 200-day moving average price is $6.73.
OraSure Technologies (NASDAQ:OSUR) last released its quarterly earnings data on Wednesday, May 4th. The company reported $0.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.02 by $0.02. The business earned $29.10 million during the quarter, compared to analysts’ expectations of $28.82 million. The company’s revenue for the quarter was up 7.4% compared to the same quarter last year. Equities analysts forecast that OraSure Technologies Inc. will post $0.25 EPS for the current fiscal year.
A number of hedge funds and institutional investors have added to or reduced their stakes in OSUR. American Century Companies Inc. acquired a new position in OraSure Technologies during the fourth quarter valued at about $1,371,000. Oxford Asset Management acquired a new position in OraSure Technologies during the fourth quarter valued at about $1,209,000. Casdin Capital LLC acquired a new position in OraSure Technologies during the fourth quarter valued at about $1,095,000. Finally, Morgan Stanley boosted its position in OraSure Technologies by 40.9% in the fourth quarter. Morgan Stanley now owns 363,707 shares of the company’s stock valued at $2,342,000 after buying an additional 105,627 shares during the last quarter.
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices and other diagnostic products designed to detect or diagnose critical medical conditions. These products include OraQuick In-Home HIV Test, OraQuick ADVANCE, OraSure HIV-1 oral specimen collection device, OraQuick HCV rapid antibody test, Intercept oral fluid drug testing system, OraSure QuickFlu Rapid Flu A&B Test and Q.E.D.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.